Biopharmaceutical research company modernizes its technology infrastructure | HCLTech

Biopharmaceutical research company modernizes its technology infrastructure

Gilead migrated to a hybrid IT environment to leverage best-of-breed cloud applications, but its environment was complex, consisting of more than 100 cloud and on-premises applications and platforms deployed cross business units. The company leveraged a legacy services-oriented architecture (SOA) to connect backend ERP and CRM systems, as well as internal and external systems for labs, drug manufacturing, and product lifecycle management. Yet the code-heavy SOA platform didn’t provide flexible connectivity across disparate data sources that would better serve IT’s customers – employees, patients, and hospitals. It didn’t enable data sharing across systems and people, which inhibited time to market for new products and services and brought on considerable technical debt.